atopic dermatitis

Great data! Huge potential! (Too bad it failed the primary endpoint)
Great data! Huge potential! (Too bad it failed the primary endpoint)
Endpoints
Vanda Pharmaceuticals
tradipitant
atopic dermatitis
Flag link:
AbbVie preps JAK atopic dermatitis candidate for phase 3
AbbVie preps JAK atopic dermatitis candidate for phase 3
Fierce Biotech
AbbVie
JAK inhibitors
clinical trials
atopic dermatitis
Upadacitinib
Sanofi
Regeneron
Dupixent
Flag link:
AbbVie adds more stellar data on ABT-494 — this time for atopic dermatitis
AbbVie adds more stellar data on ABT-494 — this time for atopic dermatitis
Endpoints
AbbVie
ABT-494
atopic dermatitis
Upadacitinib
Flag link:
Is Another Blockbuster Drug on the Way for Regeneron Pharmaceuticals, Inc.?
Is Another Blockbuster Drug on the Way for Regeneron Pharmaceuticals, Inc.?
Motley Fool
Regeneron
Dupixent
Sanofi
atopic dermatitis
Flag link:
Galderma licenses PhII atopic dermatitis drug from Roche’s Chugai
Galderma licenses PhII atopic dermatitis drug from Roche’s Chugai
Fierce Biotech
Galderms
atopic dermatitis
Roche
Chugai
nemolizumab
Flag link:
Regeneron Pharmaceuticals Inc Jumps on Positive Clinical Data
Regeneron Pharmaceuticals Inc Jumps on Positive Clinical Data
Motley Fool
Regeneron
clinical trials
dupilumab
eczema
atopic dermatitis
Flag link:
Anacor Shares Surge To All-Time Highs After Phase 3 Trials Of Eczema Drug
Anacor Shares Surge To All-Time Highs After Phase 3 Trials Of Eczema Drug
Yahoo/Benzinga
Anacor
clinical trials
eczema
crisaborole
atopic dermatitis
Flag link:
Vanda's eczema drug fails mid-stage study, shares fall
Vanda's eczema drug fails mid-stage study, shares fall
Yahoo/Reuters
Vanda Pharmaceuticals
eczema
atopic dermatitis
tradipitant
Flag link:
Sanofi-Regeneron drug tames eczema in study
Sanofi-Regeneron drug tames eczema in study
Yahoo/Reuters
Sanofi
Regeneron
eczema
atopic dermatitis
dupilumab
Flag link:
Anacor Rises on Positive Data
Anacor Rises on Positive Data
Yahoo/Zacks.com
Anacor
atopic dermatitis
AN2728
Flag link:
Anacor Pharmaceuticals to Present Clinical Data on Tavaborole and AN2728 at Upcoming Medical Meetings
Anacor Pharmaceuticals to Present Clinical Data on Tavaborole and AN2728 at Upcoming Medical Meetings
PharmiWeb
Tavaborole
Anacor
AN2728
atopic dermatitis
Onychomycosis
antifungals
Flag link: